Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study
Status:
Not yet recruiting
Trial end date:
2027-09-01
Target enrollment:
Participant gender:
Summary
This is a prospective, multi-center, real-world study designed to evaluate the efficacy and
safety of albumin-bound paclitaxel versus paclitaxel or docetaxel in adjuvant treatment of
breast cancer.